
|Articles|November 15, 2003
FDA panel recommends OK for STAAR's ICL
Monrovia, CA-The FDA's Ophthalmic Devices Panel of the Center for Devices and Radiological Health is recommending that STAAR Surgical Co.'s Implantable Contact Lens (ICL) be approved with conditions for use in correcting ?3 to ?15 D of myopia and reducing myopia in the range of ?15 to ?20 D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
2
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
3
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
4
Expanding the ICRS toolkit: Keraring for high regular astigmatism
5





















